Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

17-02-2014 Business Wire HealthComments (0)


Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it has commenced a $150 million underwritten public offering of its Class A common stock. All of the shares are being offered by Ironwood. Ironwood will grant the underwriters a 30-day option to purchase additional shares equal to up to 15% of the number of shares of Class A common stock sold in the offering. Ironwood intends to use the net proceeds from this offering to support the commerciali

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top